G Ghiringhelli

Bone Mineral Density and Bone Size in Men With Primary Osteoporosis and Vertebral Fractures

Eduardo A. Vega, G Ghiringhelli, C. Mautalén et al. · Calcified Tissue International · 1998 · 101 citations

Bone Disease, Bone Health, Primary Osteoporosis +8

Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.

C. Mautalén, C. Casco, D. González et al. · BMJ · 1984 · 43 citations · Full text

Bone Disease, Bone Health, Cardiovascular Disease +12

Efficacy of the bisphosphonate APD∗∗(Note on the nomenclature: Traditional abbreviations for identifying compounds have been used in the text. According to IUPAC: Nomenclature of Organic Chemistry, Sections A-H (Pergamon Press, Oxford, 1979), the new abbreviations are as follows: APD = AHP1BP: 3-amino-1-hydroxypropylidene-1,1-bisphosphonate EHDP = HEBP: 1-hydroxyethylidene-1,1-bisphosphonate Cl2MDP = Cl2MBP: Dichloromethylenebisphosphonate. in the control of Paget's bone disease

C. Mautalén, D. González, G Ghiringhelli · Bone · 1985 · 35 citations

Bone Disease, Molecular Pharmacology, Medicinal Chemistry +9

[Clinical, humoral and scintigraphic assessment of a bisphosphonate as potential treatment of diaphyseal dysplasia: Ribbing and Cammurati-Engelmann diseases].

de Rubin Zs, G Ghiringhelli, Mansur Jl · PubMed · 1997 · 14 citations

Bone Disease, Progressive Diaphyseal Dysplasia, Scintigraphic Assessment +13

[Bone mineral density of the lumbar spine and proximal femur of normal females in Buenos Aires].

C. Mautalén, Zachary Rubin, Eduardo A. Vega et al. · PubMed · 1990 · 11 citations

Bone Disease, Lumbar Spine, Bone Health +15